Comparison of efficacy between robot-assisted and uniportal video-assisted thoracoscopic lobectomy
- VernacularTitle:机器人与单孔电视胸腔镜肺叶切除术的疗效比较
- Author:
Run PAN
1
;
Jia JIAO
1
;
Ming DU
1
Author Information
1. Department of Thoracic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400000, P.R.China
- Publication Type:Journal Article
- Keywords:
Robot-assisted thoracoscopic surgery;
uniportal video-assisted thoracoscopic surgery;
lobectomy;
perioperative results
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2021;28(05):519-523
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the perioperative efficacy and safety of robot-assisted thoracoscopic surgery (RATS) and uniportal video-assisted thoracoscopic surgery (UVATS) in the lobectomy for early lung adenocarcinoma. Methods Clinical data of 70 early lung adenocarcinoma patients, receiving RATS or UVATS lobectomy by the same surgical team in our hospital from November 2018 to May 2020 were retrospectively analyzed. There were 24 males and 46 females with an average age of 59.3±8.9 years. According to different surgical methods, the patients were divided into a RATS group (31 patients) and a UVATS group (39 patients). The operation time, intraoperative blood loss, postoperative hospital stay, indwelling time, drainage volume, number of lymph node dissected, stations of lymph node dissected and perioperative complications were compared between the two groups. Results There was no conversion to thoracotomy or perioperative death in both groups. There was no significant difference in intraoperative blood loss, postoperative hospital stay, indwelling time of thoracic drainage tube, thoracic drainage volume or stations of lymph node dissected between the two groups (P>0.05). There was no significant difference in the incidence of pulmonary infection, persistent lung leakage, chylothorax, arrhythmia or overall complications between the two groups (P>0.05). The operation time of the RATS group was longer than that of the UVATS group (195.8±52.8 min vs. 154.0±43.1 min, P=0.001). The number of lymph node dissected in the RATS group was more than that of the UVATS group (P=0.016). Conclusion Both RATS and UVATS are safe and feasible in the treatment of lung cancer. The number of lymph nodes removed by RATS is significantly more than that of UVATS.
